摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(2-aminoquinolin-6-yl)methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide | 1347633-90-2

中文名称
——
中文别名
——
英文名称
N-[(2-aminoquinolin-6-yl)methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide
英文别名
——
N-[(2-aminoquinolin-6-yl)methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide化学式
CAS
1347633-90-2
化学式
C25H32N4O5S
mdl
——
分子量
500.619
InChiKey
RDUOVIITYYQVHZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    123
  • 氢给体数:
    1
  • 氢受体数:
    8

文献信息

  • NOVEL COMPOUNDS
    申请人:Hauel Norbert
    公开号:US20110294775A1
    公开(公告)日:2011-12-01
    Novel compounds which are useful for treating acute pain, visceral pain, neuropathic pain, inflammatory/pain receptor-mediated pain, tumour pain and headache diseases. The following is exemplary:
    新颖的化合物,可用于治疗急性疼痛、内脏疼痛、神经痛、炎症/疼痛受体介导的疼痛、肿瘤疼痛和头痛疾病。以下是示例:
  • ARYLSULFONAMIDE MIT ANALGETISCHER WIRKUNG
    申请人:Boehringer Ingelheim International GmbH
    公开号:EP2188251B1
    公开(公告)日:2015-04-29
  • Compounds
    申请人:Kauffmann-Hefner Iris
    公开号:US20090137545A1
    公开(公告)日:2009-05-28
    The present invention relates to compounds of general formula I wherein A, B, D, Y, R 1 , R 2 , R 3 , R 4 and R 5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
  • New Compounds
    申请人:KAUFFMANN-HEFNER Iris
    公开号:US20110021488A1
    公开(公告)日:2011-01-27
    The present invention relates to compounds of general formula I wherein A, B, D, Y, R 1 , R 2 , R 3 , R 4 and R 5 are defined as in the specification, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the pharmaceutical compositions containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
  • US7858618B2
    申请人:——
    公开号:US7858618B2
    公开(公告)日:2010-12-28
查看更多